Sanofi Consumer Sales Slow As Pandemic-Driven Surge Ends, But OTC Xyzal Line Still Shines

Xyzal , Sanofi Q
The Xyzal OTC allergy line was a bright spot in Sanofi's second-quarter consumer health results.

More from Business

More from Wellness